Skip to content
2000
Volume 14, Issue 3
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background: Hemocoagulase agkistrodon has been widely used for visceral bleeding, however, its adverse reaction has not been fully recognized. Case Report: A 65-year-old female with upper gastrointestinal hemorrhage occurred severe coagulation disorder during her hospitalization. Transfusion of blood products can not improve coagulation function. Coagulation parameters returned to normal two days after discontinuation of hemocoagulase agkistrodon. Conclusion: So intravenous administration of hemocoagulase should be cautiously used for the treatment of gastrointestinal bleeding.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886314666190524093711
2019-11-01
2025-01-10
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886314666190524093711
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test